Univ of Montreal leads partnership to accelerate cancer therapeutics


A consortium of more than 75 research groups has received new funding to accelerate the development of new and innovative medicines combatting cancer. The Unit for the Discovery of Medicines at the Univ of Montreal (UDM2) is establishing a commercialization unit to move innovative discoveries along the drug discovery chain more quickly and effectively by linking its discovery portfolio and technological platforms to new partners that include innovative pharmaceutical companies.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.